A Descriptive Study of Methotrexate-Related Gastrointestinal Adverse Events

被引:0
|
作者
Ahmed, Nehad J. [1 ]
Alahmari, Abdullah K. [1 ]
机构
[1] Prince Sattam Bin Abdulaziz Univ, Coll Pharm, Dept Clin Pharm, Alkharj, Saudi Arabia
来源
LATIN AMERICAN JOURNAL OF PHARMACY | 2023年 / 42卷 / 02期
关键词
adverse events; FAERS; methotrexate; reporting; VigiBase; JUVENILE IDIOPATHIC ARTHRITIS; CHILDREN; VALIDATION; TOXICITY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Methotrexate is widely used in the treatment of neoplasms, psoriasis, and rheumatoid arthritis but it can cause several adverse events. The gastrointestinal system is where methotrexate side effects occur most frequently. This was a retrospective, descriptive analysis that was conducted to analyze gastrointestinal adverse events of methotrexate that were reported to the Food and Drug Administration or to the World Health Organization. Methotrexate use has been linked to gastrointestinal side effects such as nausea, vomit-ing, diarrhea, stomach pain, stomatitis, and mouth ulcers. Methotrexate can be effective and safe when used and monitored properly, therefore it's critical to periodically check on patients and inform them of the side effects of methotrexate use and how to prevent or manage them.
引用
收藏
页码:369 / 373
页数:5
相关论文
共 50 条
  • [21] Biomarkers for gastrointestinal adverse events related to thiopurine therapy
    Giulia Zudeh
    Raffaella Franca
    Gabriele Stocco
    Giuliana Decorti
    World Journal of Gastroenterology, 2021, 27 (38) : 6348 - 6356
  • [22] Checkpoint inhibitors and gastrointestinal immune related adverse events
    Pernot, Simon
    Ramtohul, Toulsie
    Taieb, Julien
    CURRENT OPINION IN ONCOLOGY, 2016, 28 (04) : 264 - 268
  • [23] Biomarkers for gastrointestinal adverse events related to thiopurine therapy
    Zudeh, Giulia
    Franca, Raffaella
    Stocco, Gabriele
    Decorti, Giuliana
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (38) : 6348 - 6356
  • [24] Optimization of the effectiveness and cytocompatibility of Nigella sativa as a co-treatment for reducing methotrexate-related adverse effects
    Ahmed E.
    Abd-ellatief R.
    Ali M.
    Saleh T.
    Ahmed E.
    Comparative Clinical Pathology, 2020, 29 (1) : 287 - 296
  • [25] Clinicopathological characteristics of methotrexate-related lymphoproliferative disorder of the thyroid: A study of 11 patients
    Suzuki, Ayana
    Hirokawa, Mitsuyoshi
    Kawakami, Makoto
    Hashimoto, Yuko
    Muramatsu, Moe
    Miyauchi, Akira
    Akamizu, Takashi
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2024, 73
  • [26] METHOTREXATE-RELATED LYMPHOPROLIFERATIVE DISORDER IN RHEUMATOID-ARTHRITIS
    HENCH, PK
    DELZOPPO, GJ
    ROBBINS, BA
    ARTHRITIS AND RHEUMATISM, 1992, 35 (09): : S149 - S149
  • [27] METHOTREXATE-RELATED MULTIFOCAL AXONOPATHY - REPORT OF AN AUTOPSY CASE
    SHIBUTANI, M
    OKEDA, R
    HORI, A
    SCHIPPER, H
    ACTA NEUROPATHOLOGICA, 1989, 79 (03) : 333 - 335
  • [28] METHOTREXATE-RELATED PULMONARY COMPLICATIONS IN RHEUMATOID-ARTHRITIS
    BARRERA, P
    LAAN, RFJM
    VANRIEL, PLCM
    DEKHUIJZEN, PNR
    BOERBOOMS, AMT
    VANDEPUTTE, LBA
    ANNALS OF THE RHEUMATIC DISEASES, 1994, 53 (07) : 434 - 439
  • [29] The ImmunoTOX multidisciplinary board: A descriptive study of collaborative management of immune-related adverse events
    Michot, J-M.
    Lappara, A.
    Simonaggio, A.
    Danlos, F-X.
    Belkhir, R.
    Collins, M.
    Berdelou, A.
    Cauquil, C.
    Edhery, S.
    Le Pavec, J.
    Eleonora, D. M.
    Mateus, C.
    Hollebecque, A.
    Varga, A.
    Soria, J-C.
    Massard, C.
    Voisin, A-L.
    Marabelle, A.
    Champiat, S.
    Lambotte, O.
    ANNALS OF ONCOLOGY, 2019, 30 : 719 - 719
  • [30] METHOTREXATE-RELATED NEUROTOXICITY IN THE TREATMENT OF OSTEOSARCOMA: LONG TERM OUTCOME
    Christin, Anne
    Gaspar, Nathalie
    Brugieres, Pierre
    Longaud, Audrey
    Raimondo, Graziella
    Semeraro, Michaela
    Brugieres, Laurence
    PEDIATRIC BLOOD & CANCER, 2011, 57 (05) : 717 - 717